Cyclopamine CAS: 4449-51-8

CAS NO: 4449-51-8
Cyclopamine
Chemical Name: CYCLOPAMINE
Molecular Formula: C27H41NO2
Formula Weight: 411.62
CAS No.: 4449-51-8
Description Review
Description

Cyclopamine is a natural chemical compound that is found in the corn lily plant (Veratrum californicum). It has gained significant attention in recent years due to its potential therapeutic properties, particularly in the treatment of certain types of cancer. In this article, we will provide an overview of Cyclopamine, including its chemical properties, potential health benefits, side effects, dosing information, and safety considerations.

Chemical Properties:

Chemical name: Cyclopamine Molecular formula: C27H41NO2 Formula weight: 411.63 g/mol CAS No.: 4449-51-8

Top ten keywords from Google and Synonyms:

  1. Cyclopamine
  2. Cancer Treatment
  3. Hedgehog Pathway
  4. Anti-inflammatory
  5. Neuroprotective
  6. Apoptosis
  7. Skin Diseases
  8. Osteoporosis
  9. Cardiovascular Disease
  10. Autoimmune Disorders

Synonyms: 11-Deoxojervine.

Health Benefits:

Cyclopamine has been shown to have potential therapeutic benefits in the following areas:

  1. Cancer Treatment: Cyclopamine may be effective in treating certain types of cancer by inhibiting the Hedgehog signaling pathway, which is involved in tumor growth and progression.
  2. Anti-inflammatory: Cyclopamine has been shown to exhibit anti-inflammatory properties by reducing the production of pro-inflammatory cytokines and enzymes.
  3. Neuroprotection: Cyclopamine may have neuroprotective effects by promoting neural cell survival and growth and protecting against oxidative stress and inflammation.
  4. Apoptotic Activity: Cyclopamine can induce apoptosis (cell death) in cancer cells and other abnormal cells, making it a potential treatment for various diseases.
  5. Skin Diseases: Cyclopamine can inhibit abnormal skin cell proliferation and reduce inflammation, making it a potential treatment for skin diseases such as psoriasis and basal cell carcinoma.
  6. Osteoporosis: Cyclopamine may help prevent bone loss and promote bone formation by inhibiting osteoclast activity and promoting osteoblast differentiation.
  7. Cardiovascular Disease: Cyclopamine may have cardioprotective effects by reducing inflammation and oxidative stress and improving lipid metabolism.
  8. Autoimmune Disorders: Cyclopamine may help treat autoimmune disorders by suppressing immune activation and reducing inflammation.

Potential Effects:

  1. Hair Regrowth: Cyclopamine may have potential in promoting hair regrowth by inhibiting the activity of hair follicle stem cells.
  2. Male Contraceptive: Cyclopamine may have potential as a male contraceptive by inhibiting sperm production.
  3. Alzheimer’s Disease: Cyclopamine may have therapeutic potential for Alzheimer’s disease by reducing amyloid beta protein accumulation in the brain.

Product Mechanism:

The exact mechanisms by which Cyclopamine exerts its health benefits are not fully understood but appear to be related to its ability to inhibit the Hedgehog signaling pathway, which is involved in many cellular processes, including tissue development, regeneration, and tumorigenesis. By inhibiting the Hedgehog pathway, Cyclopamine can induce apoptosis, reduce inflammation and oxidative stress, and suppress abnormal cell proliferation.

Safety:

Cyclopamine is a potent inhibitor of the Hedgehog signaling pathway and can be toxic if ingested or applied topically to the skin. It should only be used under medical supervision and with appropriate safety precautions.

Side Effects:

Cyclopamine can cause serious side effects, including birth defects, neurological damage, and gastrointestinal toxicity. It should not be used during pregnancy or breastfeeding. Other potential side effects include nausea, vomiting, diarrhea, and headaches.

Dosing Information:

Cyclopamine is not available as a dietary supplement and should only be used under medical supervision. The optimal dose of Cyclopamine varies depending on the individual's age, health status, and reasons for use.

Conclusion:

Cyclopamine is a naturally occurring compound with potential therapeutic properties, particularly in the treatment of certain types of cancer. Its ability to inhibit the Hedgehog signaling pathway makes it a promising candidate for drug development. However, Cyclopamine can be toxic if ingested or applied topically, and further research is needed to establish its long-term safety and efficacy. Overall, Cyclopamine shows promise as a potential treatment for various diseases, but caution is necessary when using this compound.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us